Synonyms: | |
Status: | Approved (1980) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N06AA21 |
UNII: | 2U1W68TROF |
InChI Key | QSLMDECMDJKHMQ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H23N |
Molecular Weight | 277.41 |
AlogP | 4.21 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 12.03 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 21.0 |
Primary Target | |
---|---|
NET |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
- | 38000 | - | - | - | |
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 31000 | - | - | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | 402 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | - | - | 2 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | - | - | 12 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Depressive Disorder | 4 | D003866 | ClinicalTrials |
Anxiety | 3 | D001007 | ClinicalTrials |
Dementia | 3 | D003704 | ClinicalTrials |
Schizophrenia | 3 | D012559 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Brain Neoplasms | 1 | D001932 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 10262-69-8 |
ChEBI | 6690 |
ChEMBL | CHEMBL21731 |
DrugBank | DB00934 |
DrugCentral | 1634 |
EPA CompTox | DTXSID7045029 |
FDA SRS | 2U1W68TROF |
Human Metabolome Database | HMDB0015069 |
Guide to Pharmacology | 2402 |
KEGG | C07107 |
PharmGKB | PA450322 |
PubChem | 4011 |
SureChEMBL | SCHEMBL33993 |
ZINC | ZINC000001530688 |